Tci Wealth Advisors, Inc. Royalty Pharma PLC Transaction History

Tci Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$32.77 - $39.4 $5,636 - $6,776	-172 Reduced 72.88%	64 $2,000
Q4 2022 Feb 06, 2023	BUY	$39.17 - $44.04 $6,071 - $6,826	155 Added 191.36%	236 $9,000
Q3 2022 Nov 08, 2022	SELL	$39.88 - $44.65 $79 - $89	-2 Reduced 2.41%	81 $3,000
Q2 2022 Jul 19, 2022	BUY	$37.53 - $44.22 $1,200 - $1,415	32 Added 62.75%	83 $3,000
Q4 2021 Jan 24, 2022	BUY	$35.17 - $42.48 $175 - $212	5 Added 10.87%	51 $2,000
Q3 2021 Oct 29, 2021	SELL	$36.14 - $42.24 $252 - $295	-7 Reduced 13.21%	46 $2,000
Q2 2021 Aug 02, 2021	BUY	$39.85 - $46.63 $199 - $233	5 Added 10.42%	53 $2,000
Q1 2021 Apr 29, 2021	BUY	$42.34 - $52.82 $762 - $950	18 Added 60.0%	48 $2,000
Q4 2020 Jan 21, 2021	BUY	$36.12 - $50.05 $686 - $950	19 Added 172.73%	30 $2,000
Q3 2020 Oct 20, 2020	BUY	$38.56 - $48.36 $424 - $531	11 New	11 $0

412

282M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $13.8B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.